The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 20, 2007
Filed:
Jun. 13, 2003
Kyoji Yamaguchi, Saitama, JP;
Hisataka Yasuda, Tochigi, JP;
Nobuaki Nakagawa, Tochigi, JP;
Nobuyuki Shima, Tochigi, JP;
Masahiko Kinosaki, Tochigi, JP;
Eisuke Tsuda, Tochigi, JP;
Masaaki Goto, Tochigi, JP;
Kazuki Yano, Tochigi, JP;
Akihiro Tomoyasu, Tochigi, JP;
Fumie Kobayashi, Tochigi, JP;
Naohiro Washida, Tochigi, JP;
Ken Takahashi, Tochigi, JP;
Tomonori Morinaga, Tochigi, JP;
Kanji Higashio, Saitama, JP;
Kyoji Yamaguchi, Saitama, JP;
Hisataka Yasuda, Tochigi, JP;
Nobuaki Nakagawa, Tochigi, JP;
Nobuyuki Shima, Tochigi, JP;
Masahiko Kinosaki, Tochigi, JP;
Eisuke Tsuda, Tochigi, JP;
Masaaki Goto, Tochigi, JP;
Kazuki Yano, Tochigi, JP;
Akihiro Tomoyasu, Tochigi, JP;
Fumie Kobayashi, Tochigi, JP;
Naohiro Washida, Tochigi, JP;
Ken Takahashi, Tochigi, JP;
Tomonori Morinaga, Tochigi, JP;
Kanji Higashio, Saitama, JP;
Sankyo Co. Ltd, Tokyo, JP;
Abstract
The present invention relates to a novel protein which binds to Osteoclastogenesis Inhibitory Factor (OCIF-binding molecule; OBM), a process for preparing the same, DNA encoding said protein, a protein having an amino acid sequence encoded by this DNA, a method for producing said protein by genetic engineering technique, and a pharmaceutical composition containing said protein. In addition, screening methods for a substance for controlling expression of said protein using said protein and the DNA, a substance which inhibits or protein through binding to said protein, the substance obtained by the screening methods, and a pharmaceutical composition which contains this substance are disclosed. An antibody for said protein, a process for preparing the same, a measuring method of said protein using the antibody, and a medicine comprising the antibody are also disclosed.